Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Storr

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Zeitschrift Fur Gastroenterologie|April 8, 2025
[Guideline on functional dyspepsia, a disorder of gut-brain-interaction (DGBI): S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM)]Martin Storr, Viola Andresen, Thomas Frieling, et al.
Zeitschrift Fur Gastroenterologie|May 15, 2023
[Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]Andreas Stallmach, Lutz von Müller, Martin Storr, et al.
Zeitschrift Fur Gastroenterologie|November 13, 2018
[Interpretation und performance of high-resolution esophageal manometry: Recommendations of the German Association of Neurogastroenterology and Motility (DGNM) and the German Association of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]Jutta Keller, Mark Robert Fox, Hans-Dieter Allescher, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 6, 2013
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitisYu Y Li, Birol Yuece, Hua M Cao, et al.
Plos One|July 12, 2013
The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileusYong-yu Li, Ming-hua Cao, Brigitte Goetz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infectionsChristian Bestfater, Maria J G T Vehreschild, Andreas Stallmach, et al.
The American Journal of Gastroenterology|November 26, 2024
A Phase II, Multicentric, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhea-Predominant Irritable Bowel SyndromeLukas Michaja Balsiger, Javier Santos, Jordi Serra, et al.
Angewandte Chemie (International Ed. in English)|August 20, 2013
Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40Li-Mei Yan, Aleksandra Velkova, Marianna Tatarek-Nossol, et al.
Plos One|February 25, 2012
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitisJosep Bassaganya-Riera, Monica Viladomiu, Mireia Pedragosa, et al.
Inflammatory Bowel Diseases|July 12, 2011
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentRudolf Schicho, Mohammad Bashashati, Misha Bawa, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Zeitschrift Fur Gastroenterologie|April 8, 2025
[Guideline on functional dyspepsia, a disorder of gut-brain-interaction (DGBI): S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM)]Martin Storr, Viola Andresen, Thomas Frieling, et al.
Zeitschrift Fur Gastroenterologie|May 15, 2023
[Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]Andreas Stallmach, Lutz von Müller, Martin Storr, et al.
Zeitschrift Fur Gastroenterologie|November 13, 2018
[Interpretation und performance of high-resolution esophageal manometry: Recommendations of the German Association of Neurogastroenterology and Motility (DGNM) and the German Association of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]Jutta Keller, Mark Robert Fox, Hans-Dieter Allescher, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 6, 2013
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitisYu Y Li, Birol Yuece, Hua M Cao, et al.
Plos One|July 12, 2013
The dual effect of cannabinoid receptor-1 deficiency on the murine postoperative ileusYong-yu Li, Ming-hua Cao, Brigitte Goetz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infectionsChristian Bestfater, Maria J G T Vehreschild, Andreas Stallmach, et al.
The American Journal of Gastroenterology|November 26, 2024
A Phase II, Multicentric, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhea-Predominant Irritable Bowel SyndromeLukas Michaja Balsiger, Javier Santos, Jordi Serra, et al.
Angewandte Chemie (International Ed. in English)|August 20, 2013
Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40Li-Mei Yan, Aleksandra Velkova, Marianna Tatarek-Nossol, et al.
Plos One|February 25, 2012
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitisJosep Bassaganya-Riera, Monica Viladomiu, Mireia Pedragosa, et al.
Inflammatory Bowel Diseases|July 12, 2011
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentRudolf Schicho, Mohammad Bashashati, Misha Bawa, et al.
Pageof 16